【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 内部交易: 2021-01-26,总裁 and CEO,Sullivan Keith J ,卖出,22829普通股, $18.83
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000058 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-21-020936 Act: 33 Size: 528 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-21-020872 Act: 34 Size: 9 MB 网页链接
$Neuronetics(STIM)$ 内部交易: 2021-01-22,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,12696普通股, $21.28
$Neuronetics(STIM)$ 内部交易: 2021-01-21,CFO,Furlong Stephen ,卖出,7585普通股, $18.21
$Neuronetics(STIM)$ 内部交易: 2021-01-21,VP of Prod. Dev. & Operations,Harper Gregory ,卖出,2969普通股, $18.21
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000051 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000052 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000925421-21-000053 Size: 5 KB 网页链接